Rebuilding a sports brand's core range
Five products in production from late 2023
At a glance
- Capsules and a powder
- TGA-listed medicines and food
- Includes Testofen®, a clinically studied fenugreek extract
- Five products, reformulation to reorder
The brand
A private-equity-backed Australian sports and wellness brand, turning over A$24 million a year by 2019 and exporting to New Zealand, the UK and the UAE.
The challenge
Several of its best-known formulas had room to improve on ingredient quality, dose and permitted indications.
What we built
Four TGA-listed capsules, reformulated from scratch (one built on Testofen®, a clinically studied fenugreek extract), plus a food-pathway performance powder. We handled the TGA listings, stability protocols and label review, and managed manufacturing.
Manufacturing and delivery
We managed manufacturing for all five products and every reorder, and worked through a co-packer delay, through to delivery.
The result
- Five products in production from late 2023
- Reorders on three of them within a year
Related case studies
Related case studies
Nine products and a long partnership
Five production batches from 2021 to 2025
Read the story →
Practitioner-recommended natural medicine, formulated from clinical evidence
A brand in practitioner clinics and premium retailers across Australia and New Zealand, a member of 1% for the Planet, and expanding into new markets
Read the story →
A hair care brand that keeps coming back
Working together since 2021
Read the story →